RICHARTZ et al v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al

DocketCase transferred from New Jersey has been opened in Southern District of Florida as case 9:23-cv-81118. (mg) (Entered: 08/04/2023)

DocketCase electronically transferred to the USDC for the Southern District of Florida. (jjc, ) (Entered: 08/04/2023)

Docket(#5) Order of MDL Panel (CTO-118) transferring case to the Southern District of Florida. (jjc, ) (Entered: 08/04/2023)

Docket(#4) NOTICE of Appearance by VINCENT CHENG on behalf of All Plaintiffs (CHENG, VINCENT) (Entered: 07/24/2023)

DocketCLERK'S QUALITY CONTROL MESSAGE - The case you electronically filed has been processed, however, the following deficiencies were found: All defendants were not added to the docket. When entering parties make sure to add ALL PLAINTIFFS AND DEFENDANTS as found on the original state court complaint. The Clerk's Office has made the appropriate changes. Please refer to the Attorney Case Opening Guide for processing electronically filed cases. (jjc, ) (Entered: 07/06/2023)

DocketCLERK'S QUALITY CONTROL MESSAGE - Please be advised, pursuant to Fed. R. Civ. P. 7.1, a disclosure statement is required to be filed by parties and intervenors in diversity actions to identify the citizenship of every individual or entity whose citizenship is attributed to that party or intervenor. Such disclosure statements must be filed with the parties, intervenors or proposed intervenors first appearance, pleading, petition, motion, response or other request addressed to the Court. (kht) (Entered: 07/06/2023)

DocketJudge Michael A. Shipp and Magistrate Judge Douglas E. Arpert added. (kht) (Entered: 07/06/2023)

Docket(#3) NOTICE of Appearance by TIMOTHY IGNATIUS DUFFY on behalf of BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation (DUFFY, TIMOTHY) (Entered: 07/05/2023)

Docket(#2) Corporate Disclosure Statement by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (SILVER, MARK) (Entered: 07/05/2023)

Docket(#1) NOTICE OF REMOVAL by Boehringer Ingelheim Corporation, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim USA Corporation from Superior Court of New Jersey, Middlesex County, case number MID-L-005126-22. ( Filing and Admin fee $ 402 receipt number ANJDC-14431501), filed by Boehringer Ingelheim Corporation, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3 - Part 1, #4 Exhibit 3 - Part 2, #5 Exhibit 3 - Part 3, #6 Exhibit 3 - Part 4, #7 Exhibit 3 - Part 5, #8 Civil Cover Sheet)(SILVER, MARK) (Entered: 07/05/2023)